Is Perspective Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSEMKT: CATX) stock is to Buy CATX stock.
Out of 1 analyst, 0 (0%) are recommending CATX as a Strong Buy, 1 (100%) are recommending CATX as a Buy, 0 (0%) are recommending CATX as a Hold, 0 (0%) are recommending CATX as a Sell, and 0 (0%) are recommending CATX as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year CATX price target, the average CATX price target is $1.20, with the highest CATX stock price forecast at $1.20 and the lowest CATX stock price forecast at $1.20.
The Wall Street analyst predicted that Perspective Therapeutics's share price could reach $1.20 by May 19, 2024. The average Perspective Therapeutics stock price prediction forecasts a potential upside of 328.57% from the current CATX share price of $0.28.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.